This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1979 Feb 10;1(8111):317.

doi: 10.1016/s0140-6736(79)90723-2.

Mucosal protection by prostaglandin E2

C Johansson, B Kollberg, R Nordemar, S Bergström

PMID: 84963
DOI: 10.1016/s0140-6736(79)90723-2

Clinical Trial

Mucosal protection by prostaglandin E2

C Johansson et al. Lancet. 1979.

. 1979 Feb 10;1(8111):317.

doi: 10.1016/s0140-6736(79)90723-2.

Authors

C Johansson, B Kollberg, R Nordemar, S Bergström

PMID: 84963
DOI: 10.1016/s0140-6736(79)90723-2

No abstract available

PubMed Disclaimer

Similar articles

Mucosal cytoprotection by prostaglandin E2.
Cohen MM. Cohen MM. Lancet. 1978 Dec 9;2(8102):1253-4. doi: 10.1016/s0140-6736(78)92124-4. Lancet. 1978. PMID: 82757 Clinical Trial. No abstract available.
[Effect of treatment with 15/R/15-methyl derivative of prostaglandin E2 on aspirin- and indomethacin-induced damage of the mucous membrane of the upper digestive tract in rheumatoid arthritis patients].
Mach T, Bogdał J, Stachura J, Kirchmayer S. Mach T, et al. Pol Tyg Lek. 1987 Sep 21;42(38):1183-5. Pol Tyg Lek. 1987. PMID: 3438193 Polish. No abstract available.
Gastrointestinal protection by low-dose oral prostaglandin E2 in rheumatic diseases.
Kollberg B, Nordemar R, Johansson C. Kollberg B, et al. Scand J Gastroenterol. 1981;16(8):1005-8. doi: 10.3109/00365528109181019. Scand J Gastroenterol. 1981. PMID: 7038839 Clinical Trial.
[Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer].
Grigor'ev PIa, Isakov VA. Grigor'ev PIa, et al. Sov Med. 1991;(3):39-43. Sov Med. 1991. PMID: 1909055 Review. Russian. No abstract available.
Effects of E2 prostaglandins on gastric secretion and gastrointestinal mucosa.
Johansson C, Kollberg B. Johansson C, et al. Scand J Gastroenterol Suppl. 1980;58:93-7. Scand J Gastroenterol Suppl. 1980. PMID: 6988944 Review. No abstract available.

See all similar articles

Cited by

Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2.
Goldin E, Rachmilewitz D. Goldin E, et al. Dig Dis Sci. 1983 Sep;28(9):807-11. doi: 10.1007/BF01296903. Dig Dis Sci. 1983. PMID: 6136395 Clinical Trial.
Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.
Brand DL, Roufail WM, Thomson AB, Tapper EJ. Brand DL, et al. Dig Dis Sci. 1985 Nov;30(11 Suppl):147S-158S. doi: 10.1007/BF01309402. Dig Dis Sci. 1985. PMID: 3932048 Clinical Trial.
Prevention of aspirin-induced faecal blood loss by prostaglandin E2.
Cohen MM, Cheung G, Lyster DM. Cohen MM, et al. Gut. 1980 Jul;21(7):602-6. doi: 10.1136/gut.21.7.602. Gut. 1980. PMID: 7000631 Free PMC article. Clinical Trial.
16, 16-dimethyl PGE2 fails to prevent ethanol-induced drop of gastric potential difference in man.
Müller P, Fischer N, Kather H, Simon B. Müller P, et al. Dig Dis Sci. 1981 Oct;26(10):955-6. doi: 10.1007/BF01309505. Dig Dis Sci. 1981. PMID: 7285740 No abstract available.
The pathogenesis of the aspirin-related gastric lesion.
Duggan JM. Duggan JM. J R Coll Physicians Lond. 1981 Apr;15(2):117-8. J R Coll Physicians Lond. 1981. PMID: 6792349 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database